When asked how she balances work as both a clinician and researcher, Nicole Fleege, MD, doesn’t hesitate: her patients always come first. Now, two prestigious career development awards will help her advance this commitment. The Robert A. Winn Excellence in Clinical Trials Award Program recently selected Fleege for its fifth annual Winn Career Development Award […]
The following is reprinted from the December 2 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series. The Holden Emerging Leaders Council (ELC) is a distinguished group of rising experts—researchers, physicians, and scientists—committed to advancing cancer care and research. The ELC fosters collaboration among its members, enabling […]
The following is reprinted from the November 4 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series. For many women diagnosed with breast cancer, the diagnostic period (DP)—the time between the screening mammogram and the start of treatment—is often filled with uncertainty, anxiety, and distress. One patient […]
The following is reprinted from the November 4 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series. Christopher Strouse, MD, clinical assistant professor and leader of the Myeloma Multidisciplinary Oncology Group at the University of Iowa, is working tirelessly to increase access to cutting-edge clinical trials for […]
The following is reprinted from the October 21 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series. The Emerging Leaders Council (ELC) is a distinguished group of rising experts—researchers, physicians, and scientists—committed to advancing cancer care and research. The ELC fosters collaboration among its members, enabling them […]
The following is reprinted from the September 23 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. It’s been an exciting first year for Yi Huang, MD, PhD, who joined the University of Iowa’s Department of Internal Medicine—Hematology, Oncology, and Blood and Marrow Transplantation—and Holden Comprehensive Cancer Center as a new faculty member […]
The partnership between the University of Iowa Holden Comprehensive Cancer Center (HCCC) and the Iowa Cancer Consortium (the Consortium) has long been a boon for both groups. The Consortium’s mission to reduce the burden of cancer in Iowa through advocacy, equity, and collaboration is particularly in line with the cancer center’s directive of combining patient-first […]
George Weiner, MD, professor in Hematology, Oncology, and Blood & Marrow Transplantation, has been appointed to the National Cancer Institute (NCI) Board of Scientific Advisors (BSA). The NCI BSA is a committee of the nation’s best oncology researchers and advisers, who come together three times per year to discuss scientific policy, prominent research, and the […]
This January, UI Health Care began operations in one new clinic and reorganized another: the Diagnostic and Acute Care Clinics, located in the Holden Comprehensive Cancer Center (HCCC). Led by Soorih Shaikh, MBBS, MRCPi, MPH, the aim of these clinics is to reduce delays and increase quality in caring for people with cancer. The Diagnostic […]
In a celebration of excellence, one of University of Iowa Health Care’s (UIHC) own hematologist-oncologist embodies the ideals of patient care and groundbreaking research by leading his team to secure a prestigious award. Clinical Assistant Professor of Internal Medicine Christopher Strouse, MD, received the 2023 Donald D. Dorfman Award for lymphoma research in the amount […]